Welcome To International e-Conference

Coronavirus disease (Covid-19) is an infectious disease caused by a newly discovered coronavirus since December, 2019 and has spread to more than 210 countries, infecting beyond 2 million people, with more than 1,37,000 fatalities. The Covid-19 virus spreads primarily through droplets of saliva or discharge from the nose when an infected person coughs or sneezes. People with the Covid-19virus infection will experience mild to moderate symptoms including respiratory illness. Older people and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness. Most of the patients recover without requiring special treatment. No cure is available for Covid-19. Antibiotics aren't much effective against viral infections such as Covid-19. Researchers are testing a variety of possible ways for the new drug discovery and repurposing existing drugs. The FDA has approved the antiviral drug remdesivir to treat Covid-19 in hospitalized adults and children who are of age 12 and older. The FDA has also granted an emergency use authorization (EUA) for the rheumatoid arthritis drug Baricitinib to treat Covid-19 in some cases as it works against Covid-19 by reducing inflammation and having antiviral activity. It may be used in combination with Remdesivir in people who are on mechanical ventilators or need supplemental oxygen. There is an urgent need to explore various aspects of management and treatment of this disease including vaccines development. Across the globe, two vaccines from The United States of America and two vaccines from India have received EUA for the treatment.

Speakers of the e-Conference

  • Prof. Dong-Soo Shin
    Department of Chemistry, Changwon National University,
    Changwon, Kyongnam, South Korea.
  • Dr. Ian S. Haworth
    Associate Professor & Vice Chair,
    Department of Pharmacology & Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, California. USA.
  • Dr. Frederick Frankhauser
    Department Chair, Pharmaceutical Business & Administrative Sciences, Program Director, Regulatory Affairs and Health Policy, School of Pharmacy, MCPHS University, USA
  • Dr. Stephen Kerr
    Interim Dean and Professor, School of Pharmacy,
    MCPHS University, USA.
  • Dr. Marco Lolli
    Associate Professor in Medicinal Chemistry,
    Dept. Science and Drug Technology-University of Turin (UniTO), Italy.
  • Dr. Heena Patel
    Associate Director, Clinical Operations,
    Gilead Sciences, Inc., Foster City, CA. USA.
  • Dr. Bhushan Patwardhan
    Hon'ble Vice-Chairman,
    University Grants Commission, New Delhi
  • Dr. Ram Vishwakarma
    Council of Scientific & Industrial Research,
    Anusandhan Bhavan, New Delhi.
  • Dr. Hitesh Malviya
    Director, New Vaccines,
    Serum Institute of India, Pune
  • Dr. Manu Jaggi
    Chief Operating Officer,
    Dabur Research Foundation, Ghaziabad.
  • Dr. Suresh Patankar
    Clinical Physician,
    ACE Hospital, Pune
  • Dr. Asit K. Chakraborti
    Visiting Professor, Dept. of Chemistry, S S Bhatnagar Block,
    Indian Institute of Technology, Ropar, Punjab.
  • Dr. Thennati Rajmannar
    Executive Vice President,
    Sun Pharmaceuticals, Baroda.
  • Dr. Prathama Mainker
    Sr. Principal Scientist & Chair, Department of Organic Synthesis & Process Chemistry, CSIR – Indian Institute of Chemical Technology, Hyderabad.
  • Dr. Bakulesh Khamar
    Executive Director,
    Cadila Pharmaceuticals Ltd., Ahmedabad.
  • Dr. Dinesh Patel
    Sr. Vice President and Manufacturing Head,
    Cadila Pharmaceuticals Ltd., Ahmedabad.
  • Dr. Anthony Addlagatta
    Senior Principal Scientist, Applied Biology,
    CSIR – Indian Institute of Chemical Technology, Hyderabad.
  • Dr. Suman S. Thakur
    Principal Scientist, Proteomics and Cell Signaling, CSIR - Centre for Cellular and Molecular Biology (CCMB), Hyderabad.
  • Prof. Arun Shukla
    Associate Professor, Wellcome Trust-DBT Senior Fellow & Young Investigator, Indian Institute of Technology, Kanpur.
  • Dr. Souvik Maiti
    Sr. Principal Scientist, CSIR - Institute of Genomics and Integrative Biology, New Delhi.
  • Dr. Prajwal Nandekar
    Sr. Scientist, Schrodinger Inc., India.